Heparin protects basic and acidic FGF from inactivation
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of heparin or that of hexuronyl hexosaminoglygan sulfate (HHS‐4) to protect basic or acidic fibroblast growth factor (FGF) from acid or heat inactivation has been analyzed. Both freshly prepared basic and acidic FGF stimulate the growth of baby hamster kidney (BHK‐21) cells exposed to medium supplemented with transferrin and insulin. Freshly prepared basic FGF was 10 fold more potent than acidic FGF. The addition of heparin to the medium decreased the potency of basic FGF while it potentiated that of acidic FGF. Upon storage of FGF at −80°C, a decline in potency of both basic and acidic FGF was observed. Heparin, when added to the medium, potentiated their activities, which became similar to that of freshly prepared basic FGF. In order to test whether heparin could protect basic or acidic FGF from inactivation, both mitogens were exposed to acid conditions (1% trifluoroacetic acid, pH 1.08, 2 h) or heat (65°C, 5 min) which inactivate basic or acidic FGF. When exposed to such treatment in the presence of heparin or HHS‐4, basic and acidic FGF retained their potency. The effect of heparin and HHS‐4 on the bioactivity of basic and acidic FGF is truly of a protective nature, since they had no effect when added after inactivation of the mitogens. Potentiation of the bioactivity of the protected mitogens or of the inactivated one could only be observed when cells were exposed to high heparin or HHS‐4 concentrations. This indicates that heparin and HHS‐4, in addition to protecting FGF from inactivation, also acts at another locus, as yet unidentified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of FGF-2 to heparan sulfate also imparts stability to the growth factor.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [40]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Epidermal Growth Factor and a New Derivative
Savage, C. R., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44568-7 · Cited by 1,208
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Self-citationCultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
Castellot, J., Addonizio, M., Rosenberg, R., & Karnovsky, M. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.372 · Cited by 679
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Self-citationPurification of a fibroblast growth factor from bovine pituitary.
Gospodarowicz, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41631-1 · Cited by 591
Self-citationPurification of the fibroblast growth factor activity from bovine brain.
Gospodarowicz, D., Bialecki, H., & Greenburg, G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34863-9 · Cited by 492
Self-citation
Research works printed but not linked: 1
- Gospodarowicz D., 1986, Methods in Enzymology
Cited by
Items 401–500 of 902
Gospodarowicz, D. (1989) · Journal of Investigative Dermatology · doi:10.1038/jid.1989.7 · Cited by 51
“such as capillary endothelial cells, no such potentiation of the mito genic effect of aFGF by heparin can be seen [31,48].”
BackgroundSelf-citationGospodarowicz, D., Plouët, J., & Malerstein, B. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041420215 · Cited by 51
Self-citationAngiogenesis in arteries: Review
Eisenstein, R. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90019-i · Cited by 51
The neurotrophic activity of fibroblast growth factors
Sensenbrenner, M. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90031-m · Cited by 51
Extracellular Angiogenic Growth Factor Interactions: An Angiogenesis Interactome Survey
Rusnati, M., & Presta, M. (2006) · Endothelium · doi:10.1080/10623320600698011 · Cited by 50
“Heparin/HSPGs also protect FGFs from heat denaturation (Gospodarowicz and Cheng 1986) and proteolytic degradation (Coltrini et al.”
BackgroundGambarini, Â. G., Miyamoto, C. A., Lima, G. A., Nader, H. B., & Dietrich, C. P. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf00929204 · Cited by 50
“This suggests that heparin binds to the native protein structure preventing the large disruption caused by the acid pH which is known to inactivate the growth factor to a great extent [3].”
Partially structured self-associating states of acidic fibroblast growth factor
Mach, H., Ryan, J. A., Burke, C. J., Volkin, D. B., & Middaugh, C. R. (1993) · Biochemistry · doi:10.1021/bi00081a015 · Cited by 50
Monoclonal Antibodies Against Human Basic Fibroblast Growth Factor
Seno, M., Iwane, M., Sasada, R., Moriya, N., Kurokawa, T., & Igarashi, K. (1989) · Hybridoma · doi:10.1089/hyb.1989.8.209 · Cited by 50
In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide
Ćosić, I., Drummond, A. E., Underwood, J. R., & Hearn, M. T. W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf01084262 · Cited by 48
Heparin, Heparinoids and Heparin Oligosaccharides: Structure and Biological Activities
Linhardt, R. J., & Loganathan, D. (1990) · Springer eBooks · doi:10.1007/978-1-4613-0657-3_8 · Cited by 48
Heparin augments osteoclast resorption‐stimulating activity in serum
Fuller, K., Chambers, T. J., & Gallagher, A. C. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041470204 · Cited by 48
Kurokawa, M., Doctrow, S. R., & Klagsbrun, M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83289-6 · Cited by 48
Nieto, L., Canales, Á., Fernández, I. S., Santillana, E., González‐Corrochano, R., Redondo‐Horcajo, M., Cañada, F. J., Nieto, P. M., Martín‐Lomas, M., Giménez‐Gallego, G., et al. (2013) · ChemBioChem · doi:10.1002/cbic.201300313 · Cited by 47
Lafont, J. E., Baroukh, B., Berdal, A., Colombier, M., Barritault, D., Caruelle, J. P., & Jl, S. (1998) · Growth Factors · doi:10.3109/08977199809017489 · Cited by 47
Chondroitin sulfate proteoglycans are required for lung growth and morphogenesis in vitro
Shannon, J. M., McCormick‐Shannon, K., Burhans, M. S., Shangguan, X., Srivastava, K., & Hyatt, B. A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00226.2003 · Cited by 47
“HSPG binding may protect growth factors from protease degradation (27), sequester them near their site of function (24), or maintain them in active or inactive states (48).”
BackgroundNugent, M. A., & Edelman, E. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36826-7 · Cited by 47
Ogasawara, M., Karey, K. P., Marquardt, H., & Sirbasku, D. A. (1989) · Biochemistry · doi:10.1021/bi00432a052 · Cited by 47
Motomura, K., Hagiwara, A., Komi-Kuramochi, A., Hanyu, Y., Honda, E., Suzuki, M., Kimura, M., Oki, J., Asada, M., Sakaguchi, N., et al. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.001 · Cited by 46
Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology
Schutgens, F., Verhaar, M. C., & Rookmaaker, M. B. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.059 · Cited by 46
Estapé, D., van den Heuvel, J., & Rinas, U. (1998) · Biochemical Journal · doi:10.1042/bj3350343 · Cited by 46
Wen, T.-C., Matsuda, S., Yoshimura, H., Aburaya, J., Kushihata, F., & Sakanaka, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00499-u · Cited by 46
The extracellular matrix in balloon arterial injury: A novel target for restenosis prevention
Batchelor, W., Robinson, R., & Strauss, B. H. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80021-2 · Cited by 46
Rosengart, T. K., Budenbender, K. T., Duenas, M., Mack, C. A., Zhang, Q., & Isom, O. W. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70193-9 · Cited by 46
Zenjari, C., Boilly, B., Hondermarck, H., & Boilly‐Marer, Y. (1997) · Development Growth & Differentiation · doi:10.1046/j.1440-169x.1997.00003.x · Cited by 46
Mast Cells: Accessory Cells Which Potentiate Fibrosis
Gruber, B. L. (1995) · International Reviews of Immunology · doi:10.3109/08830189509056717 · Cited by 46
The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors
Dordoe, C., Huang, W., Bwalya, C., Wang, X., Shen, B., Wang, H., Wang, J., Ye, S., Wang, P., Xiaoyan, B., et al. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.07.005 · Cited by 45
Yao, Y., & Lenhoff, A. M. (2005) · Analytical Chemistry · doi:10.1021/ac048733f · Cited by 45
Nakamura, S., Ishihara, M., Obara, K., Masuoka, K., Ishizuka, T., Kanatani, Y., Takase, B., Matsui, T., Hattori, H., Sato, T., et al. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30688 · Cited by 45
Insulin binds to type V collagen with retention of mitogenic activity
Yaoi, Y., Hashimoto, K., Takahara, K., & Kato, I. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90351-t · Cited by 45
Gomm, J. J., Coope, R. C., Browne, P. J., & Coombes, R. C. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199704)171:1<11::aid-jcp2>3.0.co;2-k · Cited by 45
Suzu, S., Ohtsuki, T., Makishima, M., Yanai, N., Kawashima, T., Nagata, N., & Motoyoshi, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41855-8 · Cited by 45
Leong, N. L., Arshi, A., Kabir, N., Nazemi, A., Petrigliano, F. A., Wu, B. M., & McAllister, D. R. (2014) · Journal of Orthopaedic Research® · doi:10.1002/jor.22757 · Cited by 44
Wongpanit, P., Ueda, H. R., Tabata, Y., & Rujiravanit, R. (2010) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/092050609x12517858243706 · Cited by 44
Hagiwara, K., Khaskhely, N. M., Uezato, H., & Nonaka, S. (1999) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1999.tb02052.x · Cited by 44
Seto, S. P., Miller, T., & Temenoff, J. S. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500565x · Cited by 44
Stabilization of basic fibroblast growth factor with dextran sulfate
Kajio, T., Kawahara, K., & Kato, K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81009-b · Cited by 44
Basic fibroblast growth factor: an autocrine mitogen of rat thyroid follicular cells?
Logan, A., Black, E. G., Gonzalez, A. M., Buscaglia, M., & Sheppard, M. C. (1992) · Endocrinology · doi:10.1210/endo.130.4.1312454 · Cited by 44
Effects of Solutes on Empirical Phase Diagrams of Human Fibroblast Growth Factor 1
Fan, H., Li, H., Zhang, M., & Middaugh, C. R. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20796 · Cited by 43
Duinslaeger, L., Verbeken, G., Reper, P., Delaey, B. M., Vanhalle, S., & Vanderkelen, A. (1996) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199607000-00018 · Cited by 43
Fibroblast (heparin-binding) growing factors in neuronal development and repair
Haynes, L. W. (1988) · Molecular Neurobiology · doi:10.1007/bf02935635 · Cited by 43
“(Gospodarowicz and Cheng, 1986), but can also restore a large component of their biological activity lost on s torage in glycerol at -20~ (Schreiber et al.”
Backgrounddu Cros, D. L., Isaacs, K., & Moore, G. P. M. (1993) · Journal of Cell Science · doi:10.1242/jcs.105.3.667 · Cited by 43
Perez, M. I., & Kohn, S. R. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70072-2 · Cited by 43
In vitro stimulation of human endothelial cells by derivatized dextrans
Letourneur, D., Champion, J., Slaoui, F., & Jozefonvicz, J. (1993) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02634373 · Cited by 43
Zhang, X., Battiston, K. G., McBane, J. E., Matheson, L. A., Labow, R. S., & Santerre, J. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100614-6.00003-2 · Cited by 42
Mori, H., Shukunami, C., Furuyama, A., Notsu, H., Nishizaki, Y., & Hiraki, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608106200 · Cited by 42
Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor
Wang, Y. J., Shahrokh, Z., Vemuri, S., Eberlein, G. A., Beylin, I., & Busch, M. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-47452-2_2 · Cited by 42
“Both bFGF and aFGF display a strong interaction with the glycosaminoglycans (GAG) such as heparin and heparan sulfate, and it has been demonstrated that heparin protects bFGF and aFGF against trypsin, heat, and acid inactivation ( Gospodarowicz and Cheng, 1986 ).”
BackgroundHurley, M. M., Kream, B. E., & Raisz, L. G. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051106 · Cited by 42
Peripheral proliferative retinopathies: An update on angiogenesis, etiologies and management
Jampol, L. M., Ebroon, D. A., & Goldbaum, M. H. (1994) · Survey of Ophthalmology · doi:10.1016/0039-6257(94)90146-5 · Cited by 42
Putnins, E. E., Firth, J. D., & Uitto, V.-J. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12606233 · Cited by 44
Huang, M., & Berkland, C. J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21412 · Cited by 41
“For instance, heparin has been well established to improve the stability of many growth factors including acidic-FGF under heat and acid treatment [12, 13].”
BackgroundTellier, L. E., Miller, T., McDevitt, T. C., & Temenoff, J. S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00933b · Cited by 41
“Previous experiments have demonstrated that the FGF family of growth factors is protected by heparin 45,46 .”
Coltrini, D., Rusnati, M., Zoppetti, G., Oreste, P., Grazioli, G., Naggi, A., & Presta, M. (1994) · Biochemical Journal · doi:10.1042/bj3030583 · Cited by 39
Hsu, Y., Nybo, R. E., Sullivan, J. K., Costigan, V. J., Spahr, C. S., Wong, C., Jones, M., Pentzer, A. G., Crouse, J. A., Pacifici, R. E., et al. (1999) · Biochemistry · doi:10.1021/bi9821317 · Cited by 41
Regulation of Tissue Factor Pathway Inhibitor Expression in Smooth Muscle Cells
Pendurthi, U. R., Rao, L. V. M., Williams, J. T., & Idell, S. (1999) · Blood · doi:10.1182/blood.v94.2.579 · Cited by 41
Heparin-Mediated Release of Fibroblast Growth Factor-Like Activity into the Circulation of Rabbits
Thompson, R. W., Whalen, G. F., Saunders, K. B., Hores, T., & D'Amore, P. A. (1990) · Growth Factors · doi:10.3109/08977199009043906 · Cited by 41
Inhibition by dextran derivatives of FGF-2 plasmin-mediated degradation
Meddahi‐Pellé, A., Lemdjabar, H., Caruelle, J. P., Barritault, D., & Hornebeck, W. (1995) · Biochimie · doi:10.1016/0300-9084(96)88185-5 · Cited by 40
Collagen and heparin matrices for growth factor delivery
Schroeder-Tefft, J. A., Bentz, H., & Estridge, T. D. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00055-2 · Cited by 40
Herbert, J. M., Cottineau, M., Driot, F., Pereillo, J., & Maffrand, J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90608-9 · Cited by 40
Taguchi, T., Kishida, A., Sakamoto, N., & Akashi, M. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19980905)41:3<386::aid-jbm7>3.0.co;2-8 · Cited by 39
Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2
Hannink, G., Geutjes, P. J., Daamen, W. F., & Buma, P. (2012) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-012-4802-4 · Cited by 39
Roberts, E. L., Abdollahi, S., Oustadi, F., Stephens, E. D., & Badv, M. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00021 · Cited by 39
Thermal Stability and CD Analysis of Rat Tyrosine Hydroxylase
Gahn, L. G., & Roskoski, R. J. (1995) · Biochemistry · doi:10.1021/bi00001a030 · Cited by 34
Heparin lowers blood pressure: Biological and clinical perspectives
Mandal, A. K., LYDEN, T. W., & Saklayen, M. G. (1995) · Kidney International · doi:10.1038/ki.1995.147 · Cited by 39
Burgess, J. W., Kiss, R. S., Zheng, H., Zachariah, S., & Marcel, Y. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204200200 · Cited by 39
DeCoster, M. A., & DeVries, G. H. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490220308 · Cited by 39
“, 1986) and to protect both acidic and basic fibroblast growth factor from inactivation (Gospodarowicz and Cheng, 1986).”
Lee, J., & Blaber, M. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.026 · Cited by 38
Chrissouli, S., Pratsinis, H., Velissariou, V., Anastasiou, A., & Kletsas, D. (2010) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00626.x · Cited by 38
“This is in agreement with the results from the heat- and acid-treatment mentioned above, as PDGF is stable under these conditions, while bFGF is labile.(46,47) Of course, as stated above, the contribution of other factors cannot be excluded; however, bFGF and PDGF are necessary for this mitogenicity.”
ResultCollagen and heparin matrices for growth factor delivery
Schroeder-Tefft, J. A., Bentz, H., & Estridge, T. D. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)10055-4 · Cited by 38
Belford, D. A., Hendry, I. A., & Parish, C. R. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570124 · Cited by 38
Heparitinase inhibition of mesoderm induction and gastrulation in Xenopus laevis embryos
Brickman, M. C., & Gerhart, J. C. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1218 · Cited by 39
Morrison, R. S., Shi, E., Kan, M., Yamaguchi, F., McKeehan, W. L., Rudnicka-Nawrot, M., & Palczewski, K. (1994) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631302 · Cited by 38
Bono, F., Rigon, P., LAMARCHE, I., Savi, P., Salel, V., & Herbert, J. (1997) · Biochemical Journal · doi:10.1042/bj3260661 · Cited by 37
Cao, Y., & Pettersson, R. F. (1993) · Growth Factors · doi:10.3109/08977199308991573 · Cited by 37
Bradding, P., Walls, A. F., & Church, M. K. (1995) · Elsevier eBooks · doi:10.1016/b978-012352325-9/50006-x · Cited by 37
Biochemistry and Molecular Biology of Fibroblast Growth Factors
Thomas, K. A. (1993) · Elsevier eBooks · doi:10.1016/b978-0-08-057132-4.50013-7 · Cited by 37
Weltrowski, A., Almeida, M. D. S., Peschel, D., Zhang, K., Fischer, S., & Groth, T. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201100518 · Cited by 36
Imaizumi, T., Jean-Louis, F., Dubertret, M. L., Bailly, C., Cicurel, L., Petchot-Bacqué, J. P., & Dubertret, L. (1996) · Journal of Dermatological Science · doi:10.1016/0923-1811(95)00431-9 · Cited by 36
Effects of fibroblast growth factors and platelet-derived growth factor on food intake in rats
Sasaki, K., Oomura, Y., Suzuki, K., Muto, T., Hanai, K., Tooyama, I., Kimura, H., & Yanaihara, N. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90120-9 · Cited by 36
Scheinowitz, M., Abramov, D., & Eldar, M. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02902-6 · Cited by 36
TREATMENT OF OSTEOCHONDRAL INJURIES
Martinek, V., Fu, F. H., Lee, C. W., & Huard, J. (2001) · Clinics in Sports Medicine · doi:10.1016/s0278-5919(05)70313-6 · Cited by 36
Nadroparin Sodium Activates Nrf2/HO-1 Pathway in Acetic Acid-Induced Colitis in Rats
Yalnız, M., Demirel, U., Orhan, C., Bahçecioğlu, İ. H., Ozercan, İ. H., Aygün, C., Tuzcu, M., & Şahin, K. (2012) · Inflammation · doi:10.1007/s10753-012-9431-z · Cited by 35
Heparin's roles in stabilizing, potentiating, and transporting LEDGF into the nucleus.
Fatma, N., Singh, D. P., Shinohara, T., & Chylack, L. T. (2000) · PubMed · Cited by 35
Effect of heparin on pulmonary fibroblasts and vascular cells.
YAMASHITA, Y., Nakagomi, K., Takeda, T., Hasegawa, S., & Mitsui, Y. (1992) · Thorax · doi:10.1136/thx.47.8.634 · Cited by 35
Heath, W. F., Cantrell, A. S., Mayne, N. G., & Jaskunas, S. R. (1991) · Biochemistry · doi:10.1021/bi00236a039 · Cited by 35
Baird, A., Ueno, N., Esch, F. S., & LING, N. C. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041330419 · Cited by 35
Ledoux, D., Méreau, A., Dauchel, M. C., Barritault, D., & Courty, J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92436-4 · Cited by 35
Enerbäck, L., & Norrby, K. (1989) · Current topics in pathology · doi:10.1007/978-3-642-73855-5_8 · Cited by 35
Microglia and Stem-Cell Mediated Neuroprotection after Neonatal Hypoxia-Ischemia
Brégère, C., Schwendele, B., Radanovic, B., & Guzman, R. G. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10213-y · Cited by 34
Tan, E. M. L., Levine, E. M., Sorger, T., Unger, G. A., Hacobian, N., Planck, B., & Iozzo, R. V. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92102-5 · Cited by 34
Presta, M., Statuto, M., Isacchi, A., Caccia, P., Pozzi, A., Gualandris, A., Rusnati, M., Bergonzoni, L., & Sarmientos, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91739-d · Cited by 34
Asakai, R., Tamura, K., Eishi, Y., Iwamoto, M., Kato, Y., & Okamoto, R. (1993) · Endocrinology · doi:10.1210/endo.133.3.7689947 · Cited by 34
Single–Step Purification on DEAE–Sephacel of Recombinant Polypeptides Produced in Escherichia Coli
Ortega, S., García, J. L., Zazo, M., Varela, J., Muñoz‐Willery, I., Cuevas, P., & Giménez‐Gallego, G. (1992) · Nature Biotechnology · doi:10.1038/nbt0792-795 · Cited by 34
Immunohistochemical localization of basic fibroblast growth factor within the mouse uterus
Wordinger, R. J., Moss, A., Lockard, T., Gray, D., Chang, I.-F. C., & Jackson, T. (1992) · Reproduction · doi:10.1530/jrf.0.0960141 · Cited by 34
“…acidic FGF have a strong affinity for the anionic glycosaminoglycan, heparin (Shing et al, 1983, 1984), which appears to be a stabilizing factor that protects basic and acidic FGF from inactivation by acid and heat (Gospodarowicz & Cheng, 1986) and degradation by proteases (Sommer & Rifkin, 1989).”
BackgroundKaplow, J. M., Bellot, F., Crumley, G., Dionne, C. A., & Jaye, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80179-2 · Cited by 34
Advanced imaging of skeletal manifestations of systemic mastocytosis
Fritz, J. M., Fishman, E. K., Carrino, J. A., & Horger, M. (2012) · Skeletal Radiology · doi:10.1007/s00256-012-1374-9 · Cited by 33
“Heparin may also play a role in potentiating the action of basic fibroblast growth factor [22].”
BackgroundAtkin, S. L., Landolt, A. M., Jeffreys, R. V., Diver, M. J., Radcliffe, J. J., & White, M. C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.3.8370706 · Cited by 33
Comparative Effects of Bluetongue Virus Infection of Ovine and Bovine Endothelial Cells
Russell, H., O’Toole, D., Bardsley, K. D., Davis, W. C., & Ellis, J. A. (1996) · Veterinary Pathology · doi:10.1177/030098589603300309 · Cited by 33
Cytokines associated with the pathophysiology of aggressive fibromatosis
Mills, B. G., Frausto, A., & Brien, E. W. (2000) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100180419 · Cited by 33
Letourneur, D., Machy, D., Meddahi‐Pellé, A., Marcon-Bachari, E., D’Angelo, G., Vogel, M., Chaubet, F., & Michel, J. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10072 · Cited by 33
Hoganson, D. K., Chandler, L. A., Fleurbaaij, G. A., Ying, W., Black, M. E., Doukas, J., Pierce, G. F., Baird, A., & Sosnowski, B. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.17-2565 · Cited by 33
Metadata
- Authors
- Gospodarowicz, D., & Cheng, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gospodarowicz, D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-09
- Volume
- 128
- Issue
- 3
- Pages
- 475-484
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1972855766
- Cited by
- 853
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 18 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 22
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 20197)
- National Eye Institute (EY02186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- heparin, basic fibroblast growth factor, acidic fibroblast growth factor, acid inactivation, thermal inactivation
- MeSH terms
- Animals, Cell Division, Cell Line, Fibroblast Growth Factors, Fibroblasts, Glycosaminoglycans, Cricetinae, Hot Temperature, Heparin, Hydrogen-Ion Concentration, Insulin, Kidney, Mesocricetus, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.